|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 1,802.70 INR | +0.69% |
|
-0.36% | +32.11% |
| Market Cap | 342B 3.55B 3.1B 2.87B 2.63B 4.98B 5.07B 34.19B 13.43B 167B 13.32B 13.03B 576B | P/E 2026 |
32.7x | P/E 2027 * | 29.7x |
|---|---|---|---|---|---|
| Enterprise Value | 349B 3.62B 3.16B 2.92B 2.68B 5.08B 5.17B 34.87B 13.7B 170B 13.58B 13.28B 588B | EV / Sales 2026 |
3.33x | EV / Sales 2027 * | 3.32x |
| Free-Float |
18.3% | Yield 2026 |
0.23% | Yield 2027 * | 0.21% |
Last Transcript: Emcure Pharmaceuticals Limited
| 1 day | +0.69% | ||
| 1 week | -0.36% | ||
| Current month | -1.81% | ||
| 1 month | +5.69% | ||
| 3 months | +9.47% | ||
| 6 months | +14.78% | ||
| Current year | +32.11% |
| 1 week | 1,780.1 | 1,840 | |
| 1 month | 1,704.8 | 1,944 | |
| Current year | 1,381 | 1,944 | |
| 1 year | 1,260 | 1,944 | |
| 3 years | 889 | 1,944 | |
| 5 years | 889 | 1,944 | |
| 10 years | 889 | 1,944 |
| Manager | Title | Age | Since |
|---|---|---|---|
| Chief Executive Officer | 75 | 16/04/1981 | |
| Director of Finance/CFO | - | 01/10/2003 | |
| Compliance Officer | - | 04/02/2026 |
| Director | Title | Age | Since |
|---|---|---|---|
| Chairman | 69 | - | |
| Director/Board Member | 72 | 23/07/2001 | |
| Director/Board Member | 75 | 16/04/1981 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +0.69% | -0.36% | +32.40% | - | 3.53B | ||
| +1.08% | -3.84% | +51.50% | +160.13% | 1,031B | ||
| +1.19% | -5.10% | +61.09% | +56.36% | 595B | ||
| +4.21% | +0.65% | +36.48% | +87.04% | 431B | ||
| +0.42% | -0.99% | +30.04% | +22.27% | 326B | ||
| +1.03% | -2.10% | +28.32% | +45.08% | 277B | ||
| +0.49% | -11.32% | +20.31% | +22.32% | 263B | ||
| +1.59% | +3.91% | -22.47% | -36.84% | 224B | ||
| +3.70% | +0.98% | +27.03% | +63.38% | 193B | ||
| +3.49% | +0.35% | +24.98% | +76.58% | 164B | ||
| Average | +1.88% | -3.48% | +28.97% | +55.15% | 350.78B | |
| Weighted average by Cap. | +1.81% | -4.30% | +37.79% | +79.43% |
| 2026 | 2027 * | |
|---|---|---|
| Net sales | 91.56B 950M 831M 768M 705M 1.33B 1.36B 9.16B 3.6B 44.71B 3.57B 3.49B 154B | 104B 1.08B 947M 876M 804M 1.52B 1.55B 10.44B 4.1B 50.98B 4.07B 3.98B 176B |
| Net income | 9.81B 102M 88.99M 82.3M 75.52M 143M 145M 982M 386M 4.79B 382M 374M 16.54B | 11.5B 119M 104M 96.44M 88.5M 167M 170M 1.15B 452M 5.61B 448M 438M 19.38B |
| Net Debt | 6.75B 70.04M 61.22M 56.62M 51.96M 98.33M 100M 675M 265M 3.3B 263M 257M 11.38B | 4.56B 47.37M 41.41M 38.29M 35.14M 66.5M 67.66M 457M 179M 2.23B 178M 174M 7.7B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 16/07/26 | ₹1,802.70 | +0.69% | 120,724 |
| 15/07/26 | ₹1,790.30 | -1.09% | 95,679 |
| 14/07/26 | ₹1,810.10 | +0.94% | 138,088 |
| 13/07/26 | ₹1,793.30 | -1.16% | 87,267 |
| 10/07/26 | ₹1,814.40 | +0.27% | 74,788 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.

Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- EMCURE Stock
Select your edition
All financial news and data tailored to specific country editions


















